Disagreement among experts about public health decision making: is it polarisation and does it matter?


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
03 2023
Historique:
received: 06 11 2022
accepted: 28 02 2023
entrez: 22 3 2023
pubmed: 23 3 2023
medline: 25 3 2023
Statut: ppublish

Résumé

It is common for aspects of the COVID-19 response-and other public health initiatives before it-to be described as polarised. Public health decisions emerge from an interplay of facts, norms and preferred courses of action. What counts as 'evidence' is diverse and contestable, and disagreements over how it should be interpreted are often the product of differing choices between competing values. We propose a definition of polarisation for the context of public health expertise that acknowledges and accounts for epistemic and social values as part of evidence generation and its application to public health practice. The 'polarised' label should be used judiciously because the descriptor risks generating or exacerbating the problem by oversimplifying complex issues and positions and creating groups that seem dichotomous. 'Independence' as a one-size-fits-all answer to expert polarisation is insufficient; this solution is premised on a scientistic account of the role of evidence in decision making and does not make room for the value difference that is at the heart of both polarisation and evidence-based decision making.

Identifiants

pubmed: 36948532
pii: bmjgh-2022-011182
doi: 10.1136/bmjgh-2022-011182
pmc: PMC10032394
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Perspect Biol Med. 2008 Summer;51(3):418-31
pubmed: 18723945
BMC Infect Dis. 2021 Jul 27;21(1):710
pubmed: 34315427
BMJ. 2021 Aug 24;374:n1888
pubmed: 34429297
Public Health. 2021 May;194:86-88
pubmed: 33866149
Lancet. 2017 Mar 18;389(10074):1100-1101
pubmed: 28322817
Nature. 2021 Oct 27;:
pubmed: 34707276
Nat Rev Psychol. 2022;1(10):560-576
pubmed: 35937553
Am Psychol. 2019 Apr;74(3):301-314
pubmed: 30945893
Science. 2020 Oct 30;370(6516):533-536
pubmed: 33122374
Annu Rev Public Health. 2021 Apr 1;42:175-191
pubmed: 33798403
BMJ. 2011 Oct 25;343:d6894
pubmed: 22028484
BMJ. 2012 Feb 27;344:e1316
pubmed: 22371864
Health Policy. 2017 Jul;121(7):793-799
pubmed: 28571666
J Med Ethics. 2015 Apr;41(4):356-8
pubmed: 25605606
Am J Prev Med. 2015 Aug;49(2):274-85
pubmed: 26091929
Clin Infect Dis. 2020 Dec 3;71(9):2311-2313
pubmed: 32628269
Lancet. 2020 Oct 3;396(10256):945
pubmed: 33010826
Proc Natl Acad Sci U S A. 2022 Jan 18;119(3):
pubmed: 35042779
BMJ. 2021 Nov 22;375:n2850
pubmed: 34810157
Eur J Clin Invest. 2021 Apr;51(4):e13484
pubmed: 33400268
J Bioeth Inq. 2020 Dec;17(4):581-589
pubmed: 33169264
Acta Paediatr. 2020 Aug;109(8):1525-1530
pubmed: 32430964

Auteurs

Jane H Williams (JH)

Australian Centre for Health Engagement, Evidence and Values (ACHEEV), School of Health and Society, University of Wollongong, Wollongong, New South Wales, Australia williamsj@uow.edu.au.
School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

Claire Hooker (C)

School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

Gwendolyn L Gilbert (GL)

Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, New South Wales, Australia.

Suyin Hor (S)

School of Public Health, University of Technology Sydney, Sydney, New South Wales, Australia.

Chris Degeling (C)

Australian Centre for Health Engagement, Evidence and Values (ACHEEV), School of Health and Society, University of Wollongong, Wollongong, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH